Jiang QF - Search Results

1

[Observation on the efficacy of modified Appleby operation for carcinoma of the body and tail of the pancreas].

Shen Q, Jiang QF, Tian YW, Yu M, Jia JK, Xue HZ. Shen Q, et al. Among authors: jiang qf. Zhonghua Yi Xue Za Zhi. 2016 Feb;96(6):431-4. doi: 10.3760/cma.j.issn.0376-2491.2016.06.004. Zhonghua Yi Xue Za Zhi. 2016. PMID: 26875917 Chinese.

2

[Treatment of Budd-Chiari syndrome with occlusion of both inferior vena cava and hepatic veins lesions by interposition of graft meso-caval-atrial shunt].

Xue HZ, Wang YD, Jiang QF, Zhang HW, Shen Q. Xue HZ, et al. Among authors: jiang qf. Zhonghua Yi Xue Za Zhi. 2008 Jul 15;88(27):1912-5. Zhonghua Yi Xue Za Zhi. 2008. PMID: 19040006 Chinese.

3

[Duodenum-preserving pancreatic head resection in treating patients with chronic pancreatitis].

Shen Q, Xue HZ, Jiang QF, Wang YD. Shen Q, et al. Among authors: jiang qf. Zhonghua Yi Xue Za Zhi. 2010 Nov 30;90(44):3127-30. Zhonghua Yi Xue Za Zhi. 2010. PMID: 21211343 Chinese.

4

Appleby operation for carcinoma of the body and tail of the pancreas.

Shen Q, Jiang QF, Tian YW, Yu M, Jia JK, Xue HZ. Shen Q, et al. Among authors: jiang qf. J Cancer Res Ther. 2018 Dec;14(Supplement):S1019-S1023. doi: 10.4103/0973-1482.199383. J Cancer Res Ther. 2018. PMID: 30539839 Free article. Clinical Trial.

5

miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.

Yu M, Xue H, Wang Y, Shen Q, Jiang Q, Zhang X, Li K, Jia M, Jia J, Xu J, Tian Y. Yu M, et al. Int J Oncol. 2017 Mar;50(3):975-983. doi: 10.3892/ijo.2017.3852. Epub 2017 Jan 17. Int J Oncol. 2017. PMID: 28098858

6

Surgical operation and re-operation for hepatocellular carcinoma with bile duct thrombosis.

Wang YD, Xue HZ, Jiang QF, Shen Q, Wang LC, Zhang X, Lu B, Yu M, Li K. Wang YD, et al. Among authors: jiang qf. Chin Med J (Engl). 2010 Aug;123(16):2163-70. Chin Med J (Engl). 2010. PMID: 20819658

7

Clinical and pathological features and surgical treatment of Budd-Chiari syndrome-associated hepatocellular carcinoma.

Wang YD, Xue HZ, Zhang X, Xu ZQ, Jiang QF, Shen Q, Yu M, Li K, Jia M. Wang YD, et al. Among authors: jiang qf. Chin Med J (Engl). 2013;126(19):3632-8. Chin Med J (Engl). 2013. PMID: 24112155

8

SENP2 regulated the stability of β-catenin through WWOX in hepatocellular carcinoma cell.

Jiang QF, Tian YW, Shen Q, Xue HZ, Li K. Jiang QF, et al. Tumour Biol. 2014 Oct;35(10):9677-82. doi: 10.1007/s13277-014-2239-8. Epub 2014 Jun 27. Tumour Biol. 2014. PMID: 24969559

9

Decreased levels of miR-34a and miR-217 act as predictor biomarkers of aggressive progression and poor prognosis in hepatocellular carcinoma.

Tian YW, Shen Q, Jiang QF, Wang YX, Li K, Xue HZ. Tian YW, et al. Among authors: jiang qf. Minerva Med. 2017 Apr;108(2):108-113. doi: 10.23736/S0026-4806.16.04616-4. Epub 2016 Nov 23. Minerva Med. 2017. PMID: 27879964

10

[Portazygos disconnection in the treatment of portal hypertension].

Xue HZ, Jiang QF, Tian JG. Xue HZ, et al. Among authors: jiang qf. Zhonghua Wai Ke Za Zhi. 1994 Oct;32(10):600-2. Zhonghua Wai Ke Za Zhi. 1994. PMID: 7750417 Clinical Trial. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters